Vitamin Shoppe, Inc (NYSE:VSI) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Thursday.

VSI has been the subject of several other research reports. Zacks Investment Research upgraded shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 18th. Morgan Stanley upgraded shares of Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 target price for the company in a research note on Thursday, May 11th. Gabelli cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Thursday, May 11th. ValuEngine cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Barclays PLC restated an “equal weight” rating and issued a $13.00 target price (down previously from $24.00) on shares of Vitamin Shoppe in a research note on Sunday, May 14th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $24.00.

Vitamin Shoppe (NYSE VSI) traded up 1.39% on Thursday, reaching $10.95. 862,019 shares of the company’s stock were exchanged. The company has a market capitalization of $253.63 million, a P/E ratio of 14.09 and a beta of 0.69. The firm has a 50-day moving average price of $11.12 and a 200-day moving average price of $16.98. Vitamin Shoppe has a 1-year low of $9.80 and a 1-year high of $31.50.

Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, May 10th. The specialty retailer reported $0.37 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.21. Vitamin Shoppe had a return on equity of 9.35% and a net margin of 1.43%. The firm had revenue of $316.90 million during the quarter, compared to analyst estimates of $325.71 million. During the same quarter last year, the business posted $0.67 EPS. The firm’s revenue was down 5.9% on a year-over-year basis. Equities research analysts expect that Vitamin Shoppe will post $1.57 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/07/27/vitamin-shoppe-inc-vsi-downgraded-to-sell-at-bidaskclub.html.

Several institutional investors have recently made changes to their positions in the stock. Municipal Employees Retirement System of Michigan increased its position in shares of Vitamin Shoppe by 18.1% in the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock worth $110,000 after buying an additional 1,440 shares in the last quarter. Mason Street Advisors LLC increased its position in shares of Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock worth $112,000 after buying an additional 366 shares in the last quarter. Capstone Asset Management Co. increased its position in shares of Vitamin Shoppe by 3.5% in the second quarter. Capstone Asset Management Co. now owns 14,040 shares of the specialty retailer’s stock worth $164,000 after buying an additional 470 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new position in shares of Vitamin Shoppe during the first quarter worth about $208,000. Finally, Arizona State Retirement System increased its position in shares of Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock worth $249,000 after buying an additional 100 shares in the last quarter.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.